3Braunwald E, Antmen EM, Beasley JW, et al. ACC/ AHA 2002 guideline update for the management of patients with unstable angina and non-ST-elevation myocardial infarction: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) .Circulation, 2002, 106: 1893-1900. 被引量：1
4Fox KA,Poole-Wilson P, Clayton TC, et al. 5-Year Outcome of an Interventional Strategy in Non ST- Elevation Acute Coronary Syndrome: the British Heart Foundation RITA 3 Randomized Trial. Lancet, 2005,366:914-920. 被引量：1
5Ronner E, Boersma E, Akkerhuis KM, et al. Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein Ⅱb/Ⅲa receptor blocker. Eur Heart J, 2004, 25 : 1494- 1501. 被引量：1
6Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non ST-segment elevation acute coronary syndromes. Ann Intern Med, 2004,141 : 186-205. 被引量：1
8陈彧 万峰 江龙 等.Coronary artery bypass grafting after acute myocardial infarction[J].Journal of Peking University (health sciences),2003,35:512-514. 被引量：1
9Chew D P, Bhatt D L, Sapp S, et al. Increased mortality with oral platelet glycoprotein Ⅱb/Ⅲa antagonists: a meta-analysis of phase m multicenter randomized trials[J]. Circulation, 2001 , 103 ( 2 ) : 201 - 206. 被引量：1
10Patrono C, Coller B, FitzGerald G A, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [ J ]. Chest, 2004, 126(3 Ssuppl) : 234S-264S. 被引量：1
